Home  »  History   »   1958

1958

April 30, 2024

Kanamycin was marketed in Japan as a chemotherapeutic agent for the treatment of infections.
Furthermore, it was marketed in the U.S. and other countries around the world.
The royalties from kanamycin was used to establish the Microbial Chemistry Research Foundation: MCRF (President, Shinji Yoshino; Chairman of the Board, Hamao Umezawa; approved by the Minister of Health and Welfare).